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A 20-year-old Caucasian woman presented at the emergency unit with a complaint of lower abdominal pain, which was 
had been present for a few months but worsened on that day. The patient had no family history of cancer. She denied weight 
loss, vomiting, diarrhea, and constipation. 
The patient is a virgin, with irregular and heavy menses (6–7 days, every 33–45 days). Transabdominal ultrasound was per-
formed by an inexperienced examiner using Philips iu 22z apparatus. Gray-scale ultrasound examination revealed an irregular 
heteroechogenic solid mass (114 × 77 × 72 mm in size) in the pelvis, protruding into the abdomen on the left side (Fig. 1). 
There were no acoustic shadows and the patient reported no pain during the examination. There was only a small amount 
of fluid below the mass (Fig. 2). Color Doppler examination of the mass revealed moderate vascularization, assessed as score 
3 according to the terms and definitions established by the International Ovarian Tumor Analysis (IOTA) group (Fig. 3). The 
second ovary was irregular (40 × 28 mm), in close proximity to the pelvic mass with hypoechogenic areas, suggestive of me-
tastases. The examination revealed a hypoechogenic area of 15.5 × 17 mm in the pancreas, suggestive of metastases (Fig. 4). 
The liver and the kidneys had no focal lesions. The mass was considered as malignant according to the subjective assessment 
by the inexperienced ultrasound examiner. 
Ten selected mathematical models and scoring systems, based on clinical features, ultrasound examination and serum 
concentration of tumor markers, were used to assess the mass by the inexperienced examiner. The risk of Malignancy Algorithm 
(ROMA) revealed a high (10.24%) risk for ovarian cancer malignancy. Malignant criterion as irregular solid mass in the absence 
of other benign criteria suggested a malignant nature of the mass, according to the simple rules of the IOTA group. The results 
of the IOTA logistic regression models LR1 and LR2 were 43.7% and 23.5% respectively, indicating a malignant character of 
the lesion. The pelvic mass was considered to be malignant according to the risk of malignancy indices RMI I–IV, whose re-
sults were 512, 683, 512 and 1366, respectively. 
The Gynecologic Imaging Report and Data Sys-
tem classified the mass as grade 4, i.e. “probably 
malignant”. The ADNEX model revealed a 68.2% 
risk of malignancy, with 27.4% risk of being stage 
II–IV ovarian cancer. After obtaining the patient’s 
consent, fertility-sparing surgical operation was 
performed. The final diagnosis was dysgerminoma, 
stage IV according to the International Federation 
of Gynecology and Obstetrics (FIGO) criteria. In the 
case of our patient, advanced stage of the ovar-
ian cancer might have facilitated the diagnosis as 
the changes were evident. On the other hand, the 
rarity of the disease, young age of the patient, and 
non-specific symptoms may cause diagnostic diffi-
culties. Systemic approach, with the use of clinical, 
ultrasound and tumor markers, may help not to 
overlook ovarian cancer even in younger patients 
when assessed by inexperienced examiners. 
Figure 1. Irregular solid tumor of the 
left ovary
Figure 3. Moderate vascularization of 
the tumor
Figure 2. Small amount of fluid beneath 
the tumor
Figure 4. Pancreatic metastases
